Back to search
Myosteatosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Myosteatosis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Myosteatosis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is evaluating whether a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, tirzepatide, ca…
Some foods have components that can prevent and treat some diseases and provide beneficial effects for health. These components naturally occurring in foods are…
The investigators' pre-clinical study confirms the positive effects of combined treatment (VT + HMB) on reducing fat-to-lean tissue ratio, intramuscular fat inf…
Minimal hepatic encephalopathy (MHE) is a subclinical cognitive impairment and represents the mildest type of hepatic encephalopathy (HE). Portal hypertension i…
This randomized controlled trial aims to evaluate the effect of personalized pharmaconutrition therapy on myosteatosis, sarcopenia, and disease prognosis in pat…